Back to MLTX
Cormorant Asset Management, LP → MLTX
Cormorant Asset Management, LP MLTX Position History
MoonLake Immunotherapeutics • Healthcare
Quarters held
4
Latest value
$33.4M
Q3 2026
Peak value
$83.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $57.4M |
| Q1 2026 | $83.5M |
| Q2 2026 | $62.4M |
| Q3 2026 | $33.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $33.4M | 2.86M | — | — |
| Q2 2026 | $62.4M | 3.21M | — | — |
| Q1 2026 | $83.5M | 4.48M | — | — |
| Q4 2025 | $57.4M | 4.36M | — | — |
Other funds holding MLTX
$311.5M
$298.3M
$260.3M
$256.4M
$192.9M
$191.2M
$187.2M
$182.6M